Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Onyx Drug Shows Broader Potential in Cancer Studies
Bloomberg
Monday, April 19, 2010 - 10:57am
tags:
ONYX Pharmaceuticals, cancer, Bayer, Nexavar
Novartis Races to Be First With Oral MS Drug
Seeking Alpha
Monday, April 19, 2010 - 10:57am
tags:
Novartis, multiple sclerosis, MS, Biogen Idec, Merck
Eli Lilly Earnings Fall 5%
TheStreet.com
Monday, April 19, 2010 - 10:55am
tags:
Eli Lilly, earnings
Two Healthcare Stocks I Like Best
Seeking Alpha
Monday, April 19, 2010 - 10:55am
tags:
Abbott Laboratories, Eli Lilly, Covidien
FDA Weighs Halting Avandia Safety Study
WSJ Online
Sunday, April 18, 2010 - 3:15pm
tags:
GSK, Avandia, diabetes
Abbott Must Hand Over CEO Emails: Biotech's Latest Trials and Tribulations
Seeking Alpha
Sunday, April 18, 2010 - 12:28pm
tags:
Abbott Laboratories, Depakote, off label
Alberta wants refund on H1N1 vaccine
Calgary Herald, Canada
Sunday, April 18, 2010 - 12:27pm
tags:
H1N1 vaccines, GSK
Paxil Off-Label Use to Be Focus of Heart Defects Trial
Lawyers and Settlements
Sunday, April 18, 2010 - 12:24pm
tags:
Paxil, off label, lawsuits
Watson's Generic Toprol XL(R) 100 mg and 200 mg Receives FDA Approval
PR-USA
Sunday, April 18, 2010 - 12:22pm
tags:
Watson Pharmaceuticals, Toprol XL
Circadian's VGX-100 Significantly Inhibits Tumour Growth In Animal Models Of Human Cancer
Medical News Today
Sunday, April 18, 2010 - 12:19pm
tags:
Circadian Technologies, VGX-100, VEGF-C growth factor, cancer, Docetaxel, Avastin
Akorn, Inc. Announces FDA Approval For Hydromorphone Hydrochloride Injection 10mg/ml In 1ml, 5ml And 50ml Doses
Medical News Today
Sunday, April 18, 2010 - 12:17pm
tags:
Akorn, Dilaudid, hydromorphone hydrochloride
Cyclin-Dependent Cancer Confab Preview
Seeking Alpha
Sunday, April 18, 2010 - 12:13pm
tags:
cyclin-dependent kinase inhibition [CDK], cancer, Pfizer, Cyclacel, Merck, Sanofi, Bayer, Tragara Pharmaceutical
Rexahn Pharma Presents a Landmark in Clinical Trial Data Interpretation
Seeking Alpha
Sunday, April 18, 2010 - 12:06pm
tags:
Rexahn, Serdaxin, antidepressant
AEterna Zentaris to Raise US$15 Million in Registered Direct Offering
PR_USA
Saturday, April 17, 2010 - 1:05pm
tags:
Aeterna Zentaris, stock offering
Quebec's vaunted biotech industry 'dying'
Edmonton Journal, Canada
Saturday, April 17, 2010 - 1:04pm
tags:
biotech
New Drug Applications Approval for Five New Products in Japan
The Financial
Saturday, April 17, 2010 - 1:03pm
tags:
Japan, Nesina, type 2 diabetes, Metact, Unisa, hypertension, Rozerem, insomnia, Vectibix, cancer
Affymax and Takeda Report Phase 2 Analyses of Hematide/peginesatide in Hemodialysis Patients
PharmaLive
Saturday, April 17, 2010 - 12:58pm
tags:
Affymax, Takeda, Hematide/peginesatide, dialysis
Impax Labs amends co-promotion pact with Wyeth for Lyrica
Pharmabiz
Saturday, April 17, 2010 - 12:56pm
tags:
Impax Labs, Wyeth, Lyrica
Quebec, Ontario biotech strategy urged
Montreal Gazette, Canada
Saturday, April 17, 2010 - 12:55pm
tags:
biotech
Novartis initiates second phase-I trial for oral PTH1-34 to treat postmenopausal osteoporosis
Pharmabiz
Saturday, April 17, 2010 - 12:53pm
tags:
Novartis, Emisphere, Eligen Technology, PTH1-34, osteoporosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.